Topic

Insurance Approval

A collection of 5655 issues

How to Get Tepezza (Teprotumumab) Covered by UnitedHealthcare in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tepezza Covered by UnitedHealthcare in New York UnitedHealthcare requires prior authorization for Tepezza (teprotumumab) with specific criteria: moderate-to-severe thyroid eye disease (CAS ≥3), euthyroid status, and documented steroid failure or contraindication. Submit through the UHC Provider Portal with complete documentation including Clinical Activity Score, thyroid labs, and
7 min read

How to Get Myozyme (Alglucosidase Alfa) Covered by UnitedHealthcare in California: Complete PA Guide & Appeal Process

Answer Box: Getting Myozyme Covered by UnitedHealthcare in California UnitedHealthcare requires prior authorization for Myozyme (alglucosidase alfa) with confirmed Pompe disease diagnosis via genetic testing and enzyme assay, plus specialist evaluation. Submit through the UHC Provider Portal with complete documentation. If denied, file internal appeal within 180 days, then request
6 min read

Blue Cross Blue Shield North Carolina's Coverage Criteria for Naglazyme (Galsulfase): Complete Prior Authorization Guide

Answer Box: Getting Naglazyme Covered by Blue Cross Blue Shield of North Carolina Blue Cross Blue Shield of North Carolina requires prior authorization for Naglazyme (galsulfase) with confirmed MPS VI diagnosis via enzyme assay or genetic testing. Submit complete documentation including baseline functional assessments (6-minute walk test, stair climbing) through
7 min read

How to Get Kesimpta (Ofatumumab) Covered by UnitedHealthcare in California: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Kesimpta Covered by UnitedHealthcare in California UnitedHealthcare requires prior authorization for Kesimpta (ofatumumab) through OptumRx, with step therapy mandating documented failure of preferred MS treatments first. Submit PA via the UHC Provider Portal or fax to 1-844-403-1027. If denied, file internal appeals within 180 days, then request
6 min read